UNIBIO GROUP Current Asset

Macroaxis Equity Filters allow users to customize the simple screener criteria below or select from a set of available quick indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations

Current Asset Analysis

Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
UNIBIO GROUP 
Current Asset 
 = 
Cash 
Deposits 
Liquid Assets 
 = 
162 M

About Current Asset

Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets, since these assets can be easily liquidated in case the company goes bankrupt. However it is usually not enough to know if a company is in a good shape just based on current asset alone; the amount of current liabilities should always be considered.
Compare to competition
In accordance with recently published financial statements UNIBIO GROUP has Current Asset of 162 M. This is 99.93% lower than that of the Consumer Goods sector, and 92.81% lower than that of Packaging and Containers industry, The Current Asset for all stocks is 99.45% higher than the company.
ETFsFundsStocks

Filter other Stocks by Current Asset

Current Asset Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Found 8 equities by Current Asset
0377 HKGHUAJUN HOLD
4.6 B
1328 HKGInternational Elite Limited
656 M
3300 HKGCHINA GLASS
1.79 B
1201 HKGTESSON HOLDINGS
769 M
0690 HKGUNIBIO GROUP
162 M
0435 HKGSunlight REIT
422 M
0914 HKGANHUI CONCH
27.75 B
0493 HKGGOME
0
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Peer Comparison
UNIBIO GROUP Current Asset Comparison
UNIBIO GROUP is rated below average in current asset category among related companies.
Did you try this?
Run Portfolio Rebalancing Now
   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Hide  View All  Next  Launch Portfolio Rebalancing
Return On Equity(11.18) %
Return On Asset(5.47) %
Profit Margin(41.21) %
Operating Margin(35.23) %
Current Valuation743.49 M
Shares Outstanding5.14 B
Price to Book1.72 times
Price to Sales6.22 times
Revenue134.56 M
Gross Profit103 M
EBITDA(22.34 M)
Net Income(55.45 M)
Cash and Equivalents91.01 M
Cash per Share0.02 times
Total Debt11.51 M
Debt to Equity0.02 times
Current Ratio3.24 times
Book Value Per Share0.10 times
Cash Flow from Operations(26.08 M)
One Year High0.22
One Year Low0.13
Earnings Per Share(0.01) times
Number of Employees279
Market Capitalization821.97 M
Total Asset557 M
Retained Earnings(241 M)
Working Capital113 M
Current Asset162 M
Current Liabilities49 M
Z Score42.6